Home Other Building Blocks 331771-20-1
331771-20-1,MFCD08703125
Catalog No.:AA00C0SX

331771-20-1 | ZM 447439

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$24.00   $17.00
- +
5mg
98%
in stock  
$46.00   $32.00
- +
25mg
99%(HPLC)
in stock  
$226.00   $158.00
- +
100mg
99%(HPLC)
in stock  
$786.00   $550.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00C0SX
Chemical Name:
ZM 447439
CAS Number:
331771-20-1
Molecular Formula:
C29H31N5O4
Molecular Weight:
513.5875
MDL Number:
MFCD08703125
SMILES:
COc1cc2c(ncnc2cc1OCCCN1CCOCC1)Nc1ccc(cc1)NC(=O)c1ccccc1
Properties
Properties
 
BP:
639.671°C at 760 mmHg  
Form:
Solid  
MP:
117-120 °C  
Storage:
Keep in dry area;-20 ℃;  

Computed Properties
 
Complexity:
709  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
38  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
10  
XLogP3:
4.2  

Literature

Title: Silver nanoparticle-induced phosphorylation of histone H3 at serine 10 is due to dynamic changes in actin filaments and the activation of Aurora kinases.

Journal: Toxicology letters 20170705

Title: Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells.

Journal: Nature cell biology 20140801

Title: Centmitor-1, a novel acridinyl-acetohydrazide, possesses similar molecular interaction field and antimitotic cellular phenotype as rigosertib, on 01910.Na.

Journal: Molecular cancer therapeutics 20140501

Title: Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition.

Journal: Investigational new drugs 20120401

Title: Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin.

Journal: Carcinogenesis 20120301

Title: Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells.

Journal: Journal of cancer research and clinical oncology 20120301

Title: Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells.

Journal: PloS one 20120101

Title: Geminin overexpression induces mammary tumors via suppressing cytokinesis.

Journal: Oncotarget 20111201

Title: Formation of stable attachments between kinetochores and microtubules depends on the B56-PP2A phosphatase.

Journal: Nature cell biology 20111001

Title: ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin.

Journal: The journal of obstetrics and gynaecology research 20110601

Title: Antiproliferative effect of Aurora kinase targeting in mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands) 20101201

Title: Phosphorylation of histone H3 serine 10 in early mouse embryos: active phosphorylation at late S phase and differential effects of ZM447439 on first two embryonic mitoses.

Journal: Cell cycle (Georgetown, Tex.) 20101201

Title: The Aurora kinase inhibitor ZM447439 accelerates first meiosis in mouse oocytes by overriding the spindle assembly checkpoint.

Journal: Reproduction (Cambridge, England) 20101001

Title: Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways.

Journal: Biochemical pharmacology 20100115

Title: ZM447439, a novel promising aurora kinase inhibitor, provokes antiproliferative and proapoptotic effects alone and in combination with bio- and chemotherapeutic agents in gastroenteropancreatic neuroendocrine tumor cell lines.

Journal: Neuroendocrinology 20100101

Title: Trivalent dimethylarsenic compound induces histone H3 phosphorylation and abnormal localization of Aurora B kinase in HepG2 cells.

Journal: Toxicology and applied pharmacology 20091215

Title: Aurora kinase B modulates chromosome alignment in mouse oocytes.

Journal: Molecular reproduction and development 20091101

Title: Aurora kinase B, epigenetic state of centromeric heterochromatin and chiasma resolution in oocytes.

Journal: Reproductive biomedicine online 20090901

Title: Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.

Journal: Molecular cancer therapeutics 20090701

Title: Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit.

Journal: Molecular cancer therapeutics 20090601

Title: Discovery and development of aurora kinase inhibitors as anticancer agents.

Journal: Journal of medicinal chemistry 20090514

Title: Short and long-term tumor cell responses to Aurora kinase inhibitors.

Journal: Experimental cell research 20090415

Title: Investigating the role of Aurora kinases in RAS signaling.

Journal: Journal of cellular biochemistry 20090101

Title: Regulation of the meiotic prophase I to metaphase I transition in mouse spermatocytes.

Journal: Chromosoma 20081001

Title: Cell cycle dependent degradation of MCAK: evidence against a role in anaphase chromosome movement.

Journal: Cell cycle (Georgetown, Tex.) 20081001

Title: Aurora kinase family: a new target for anticancer drug.

Journal: Recent patents on anti-cancer drug discovery 20080601

Title: Molecular basis of drug resistance in aurora kinases.

Journal: Chemistry & biology 20080601

Title: ZM 447439 inhibition of aurora kinase induces Hep2 cancer cell apoptosis in three-dimensional culture.

Journal: Cell cycle (Georgetown, Tex.) 20080515

Title: Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts.

Journal: Haematologica 20080501

Title: Requirement of aurora-A kinase in astral microtubule polymerization and spindle microtubule flux.

Journal: Cell cycle (Georgetown, Tex.) 20080415

Title: A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia.

Journal: Molecular cancer therapeutics 20070601

Title: Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests.

Journal: International journal of radiation oncology, biology, physics 20070401

Title: MAPK interacts with XGef and is required for CPEB activation during meiosis in Xenopus oocytes.

Journal: Journal of cell science 20070315

Title: Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells.

Journal: The Journal of biological chemistry 20070309

Title: Analysis of mitotic phosphorylation of borealin.

Journal: BMC cell biology 20070101

Title: Inhibition of Aurora kinases perturbs chromosome alignment and spindle checkpoint signaling in rat spermatocytes.

Journal: Experimental cell research 20061101

Title: Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients.

Journal: Molecular cancer therapeutics 20061101

Title: Validating Aurora B as an anti-cancer drug target.

Journal: Journal of cell science 20060901

Title: Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring.

Journal: Journal of medicinal chemistry 20060810

Title: Histone post-translational modification: from discovery to the clinic.

Journal: IDrugs : the investigational drugs journal 20060601

Title: Neither Aurora B activity nor histone H3 phosphorylation is essential for chromosome condensation during meiotic maturation of porcine oocytes.

Journal: Biology of reproduction 20060501

Title: SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20060301

Title: Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors.

Journal: Journal of medicinal chemistry 20060209

Title: Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase.

Journal: FEBS letters 20050620

Title: The Ipl1/Aurora kinase family: methods of inhibition and functional analysis in mammalian cells.

Journal: Methods in molecular biology (Clifton, N.J.) 20050101

Title: Dawn of Aurora kinase inhibitors as anticancer drugs.

Journal: Expert opinion on investigational drugs 20040901

Title: Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.

Journal: The Journal of cell biology 20030428

Title: Ditchfield C, et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol. 2003 Apr 28;161(2):267-80.

Title: Long ZJ, et al. ZM 447439 inhibition of aurora kinase induces Hep2 cancer cell apoptosis in three-dimensionalculture. Cell Cycle. 2008 May 15;7(10):1473-9.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 331771-20-1
Tags:331771-20-1 Molecular Formula|331771-20-1 MDL|331771-20-1 SMILES|331771-20-1 ZM 447439